Pharmaceutical Preparations — Ranked by Total Assets
SIC 2834 · Annual figures from SEC 10-K filings
These rankings show the largest Pharmaceutical Preparations companies by total assets, based on the most recent fiscal year data reported in their annual 10-K filings with the SEC. Only companies with XBRL-tagged financial data are included. Use the tabs below to switch between revenue, net income, and total assets.
| # | Company | Total Assets | Fiscal Year |
|---|---|---|---|
| 1 | PFIZER INC PFE | $208.16B | FY2025 |
| 2 | JOHNSON & JOHNSON JNJ | $199.21B | FY2025 |
| 3 | Merck & Co., Inc. MRK | $136.87B | FY2025 |
| 4 | AbbVie Inc. ABBV | $133.96B | FY2025 |
| 5 | ELI LILLY & Co LLY | $112.48B | FY2025 |
| 6 | BRISTOL MYERS SQUIBB CO CELG-RI | $90.04B | FY2025 |
| 7 | ABBOTT LABORATORIES ABT | $86.71B | FY2025 |
| 8 | TEVA PHARMACEUTICAL INDUSTRIES LTD TEVJF | $40.75B | FY2025 |
| 9 | REGENERON PHARMACEUTICALS, INC. REGN | $40.56B | FY2025 |
| 10 | Viatris Inc VTRS | $37.19B | FY2025 |
| 11 | Bausch Health Companies Inc. BHC | $26.37B | FY2025 |
| 12 | VERTEX PHARMACEUTICALS INC / MA VRTX | $25.64B | FY2025 |
| 13 | Royalty Pharma plc RPRX | $19.62B | FY2025 |
| 14 | Zoetis Inc. ZTS | $15.47B | FY2025 |
| 15 | Elanco Animal Health Inc ELAN | $13.36B | FY2025 |
| 16 | Organon & Co. OGN | $12.87B | FY2025 |
| 17 | Jazz Pharmaceuticals plc JAZZ | $11.66B | FY2025 |
| 18 | PERRIGO Co plc PRGO | $8.54B | FY2025 |
| 19 | BeOne Medicines Ltd. BEIGF | $8.19B | FY2025 |
| 20 | UNITED THERAPEUTICS Corp UTHR | $7.88B | FY2025 |
| 21 | BIOMARIN PHARMACEUTICAL INC BMRN | $7.59B | FY2025 |
| 22 | Roivant Sciences Ltd. ROIV | $5.44B | FY2024 |
| 23 | ALNYLAM PHARMACEUTICALS, INC. ALNY | $4.97B | FY2025 |
| 24 | Amneal Pharmaceuticals, Inc. AMRX | $3.68B | FY2025 |
| 25 | IONIS PHARMACEUTICALS INC IONS | $3.52B | FY2025 |
| 26 | Prestige Consumer Healthcare Inc. PBH | $3.40B | FY2025 |
| 27 | Sarepta Therapeutics, Inc. SRPT | $3.35B | FY2025 |
| 28 | PTC THERAPEUTICS, INC. PTCT | $2.90B | FY2025 |
| 29 | Alkermes plc. ALKS | $2.49B | FY2025 |
| 30 | INSMED Inc INSM | $2.26B | FY2025 |
| 31 | OPKO HEALTH, INC. OPK | $1.93B | FY2025 |
| 32 | COLLEGIUM PHARMACEUTICAL, INC COLL | $1.66B | FY2025 |
| 33 | Innoviva, Inc. INVA | $1.64B | FY2025 |
| 34 | Amphastar Pharmaceuticals, Inc. AMPH | $1.63B | FY2025 |
| 35 | Structure Therapeutics Inc. GPCR | $1.58B | FY2025 |
| 36 | ACADIA PHARMACEUTICALS INC ACAD | $1.56B | FY2025 |
| 37 | LIGAND PHARMACEUTICALS INC LGNZZ | $1.56B | FY2025 |
| 38 | Ultragenyx Pharmaceutical Inc. RARE | $1.53B | FY2025 |
| 39 | SUPERNUS PHARMACEUTICALS, INC. SUPN | $1.45B | FY2025 |
| 40 | ANI PHARMACEUTICALS INC ANIP | $1.44B | FY2025 |
| 41 | CYTOKINETICS INC CYTK | $1.42B | FY2025 |
| 42 | Nuvalent, Inc. NUVL | $1.41B | FY2025 |
| 43 | ARROWHEAD PHARMACEUTICALS, INC. ARWR | $1.39B | FY2025 |
| 44 | PHIBRO ANIMAL HEALTH CORP PAHC | $1.36B | FY2025 |
| 45 | AbCellera Biologics Inc. ABCL | $1.36B | FY2025 |
| 46 | Emergent BioSolutions Inc. EBS | $1.32B | FY2025 |
| 47 | AGIOS PHARMACEUTICALS, INC. AGIO | $1.30B | FY2025 |
| 48 | Harmony Biosciences Holdings, Inc. HRMY | $1.27B | FY2025 |
| 49 | Pacira BioSciences, Inc. PCRX | $1.26B | FY2025 |
| 50 | MADRIGAL PHARMACEUTICALS, INC. MDGL | $1.26B | FY2025 |